Here is a focused, textbook-sourced breakdown of the antitussive action of morphine:
Antitussive Action of Morphine (Opioids)
Mechanism of Action
Morphine and other opioids suppress cough by a direct depressant effect on the medullary cough center. The brainstem cough reflex center, located in the medulla oblongata, coordinates the complex neural arc of coughing - it receives afferent input from airways and sends efferent signals to respiratory muscles. Morphine raises the threshold for this reflex, reducing its sensitivity to triggers.
- Lippincott Pharmacology: "Both morphine and codeine have antitussive properties and cause cough suppression by direct depression of the medullary cough reflex."
- Goodman & Gilman's: "Morphine, codeine, and related opioids depress the cough reflex at least in part by a direct effect on a cough center in the medulla."
Both central (medullary) and peripheral effects are thought to play a role, though the central mechanism dominates.
Key Features
| Feature | Detail |
|---|
| Site of action | Medullary cough center (brainstem) |
| Receptor type | Opioid receptors - but different from those mediating analgesia |
| Dose | Achieved at doses below those needed for analgesia |
| Correlation with analgesia | No close correlation - antitussive and analgesic effects are dissociable |
| Correlation with respiratory depression | No obligatory relationship - cough can be suppressed without depressing respiration |
| Glottal function | Protective glottal function is preserved even during cough suppression |
Receptors Involved
This is a pharmacologically important point: the receptors mediating the antitussive effect appear to be different from those mediating analgesia. Evidence for this:
- Stereoisomers of opioid molecules that have no analgesic activity or addiction liability (e.g., dextromethorphan) still produce antitussive effects.
- The antitussive dose is lower than the analgesic dose for codeine (15 mg antitussive vs. higher doses for analgesia).
(Katzung: "The receptors involved in the antitussive effect appear to differ from those associated with the other actions of opioids.")
Clinically Used Opioid Antitussives
| Drug | Notes |
|---|
| Codeine | Most commonly used opioid antitussive; 15 mg sufficient for cough suppression |
| Dextromethorphan | Synthetic morphine derivative; no analgesic/addictive properties at antitussive doses; blocks medullary cough center; also acts via NMDA receptor antagonism |
| Morphine | Has antitussive property but not preferred clinically for this indication due to addiction and side effect profile |
| Noscapine | Used outside the USA; devoid of opioid side effects |
| Levopropoxyphene | Stereoisomer of dextropropoxyphene; no opioid effects |
Dissociation from Respiratory Depression
A clinically important concept: cough suppression and respiratory depression are not obligatorily linked. Effective antitussive agents (like dextromethorphan) can suppress cough without causing respiratory depression. This is why non-analgesic opioid stereoisomers are preferred for treating cough in clinical practice.
Summary Points for Exams
- Morphine suppresses cough via direct depression of the medullary cough center.
- The antitussive receptors are distinct from analgesic receptors.
- Cough suppression occurs at sub-analgesic doses.
- There is no obligatory link between antitussive action and respiratory depression.
- Codeine is the prototypical opioid antitussive; dextromethorphan is the most widely used non-addictive alternative.
- The protective glottal reflex is preserved during opioid-induced cough suppression.
Sources: Lippincott Illustrated Reviews: Pharmacology, p. 711 | Katzung's Basic and Clinical Pharmacology 16e, p. 896 | Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 472